Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Jul 11, 2022 10:32am
200 Views
Post# 34815005

RE:RE:RE:RE:RE:JD is BTIs biggest troll.

RE:RE:RE:RE:RE:JD is BTIs biggest troll.I'm sure Frt knows what his "math" is saying. A post 1 for 30 consolidated BTI that ends up with a share price of 60¢ is the same as BTI at 2¢ today.

I'm sure Bioasis knows whether it has the accomplishments coming in the months ahead to, first, get onto Nasdaq, and to then sustain qualifications for a continued listing on Nasdaq. A clinical stage company entering clinical trials, with the xB3 platform, at 2¢? There would have to lab-proven xB3 failures and clinical trial failures to wipe out Bioasis value to that extent. 

But, you know, I suppose it should be noted that the historical BTI drop from $2.17 to 14¢, a 94% drop, is a bigger drop than 14¢ to 2¢, which is an 86% drop. 

Sorry about that.

However, Bioasis has never had as much reason than it has now to think it can get onto Nasdaq and sustain the listing. But unless there is a bunch of good news stories, then current shareholders will take the haircut before the listing, as well as after.

Everything depends more than ever on serious accomplishments, buth commercial and scientific.

jd


<< Previous
Bullboard Posts
Next >>